European guideline for the management of pelvic inflammatory disease

International Journal of STD and AIDS

Volumn 18, Issue 10, 2007, Pages 662-666

  Ross, Jonathan ^a   Judlin, Philippe ^b   Nilas, Lisbeth ^c  

^a Whittall Street Clinic ^*  (United Kingdom)

^b Maternite Regionale Universitaire   (France)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Antimicrobials; Chlamydia; Chronic pelvic pain; Ectopic pregnancy; Gonorrhoea; Infertility; Pelvic infection

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; OFLOXACIN; PROBENECID; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANAEROBIC INFECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; ECTOPIC PREGNANCY; ENDOMETRIUM BIOPSY; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; EUROPE; EVIDENCE BASED MEDICINE; FEMALE INFERTILITY; FOLLOW UP; GONORRHEA; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; INFECTION PREVENTION; LAPAROSCOPY; LEUKOCYTE COUNT; LOADING DRUG DOSE; MORBIDITY; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; PATHOGENESIS; PATIENT CARE; PATIENT EDUCATION; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PELVIS RADIOGRAPHY; PRACTICE GUIDELINE; PREGNANCY TEST; PRIORITY JOURNAL; REVIEW; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; STAPHYLOCOCCUS; STREPTOCOCCUS; ARTICLE; EUROPEAN UNION; FEMALE;

ANTI-BACTERIAL AGENTS; EUROPEAN UNION; FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 38449118338     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207782193911     Document Type: Review

References (23)

1. Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol 1995;102:407-14
2. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;55(RR-6):1-84
3. Morcos R, Frost N, Hnat M, Petrunak A, Caldito G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med 1993;38:53-6
4. Recommendations arising from the 31st Study Group. The Prevention of pelvic infection. In: Templeton A, ed. The Prevention of Pelvic Infection. London: RCOG Press, 1996;267-70
5. Kamenga MC, De Cock KM, St Louis ME, et al The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 1995;172:919-25
6. Mugo NR, Kiehlbauch JA, Nguti R, et al. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet Gynecol 2006;107:807-12
7. Bukusi EA, Cohen CR, Stevens CE, et al. Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol 1999;181:1374-81
8. Irwin KL, Moorman AC, O'Sullivan MJ, et al. Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol 2000;95:525-34
9. Altunyurt S, Demir N, Posaci C. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 2003;107:81-4
10. Yudin MH, Hillier SL, Wiesenfeld HC, Krohn MA, Amortegui AA, Sweet RL. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003;188:318-23
11. Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993;169:1143-9
12. Hillis SD, Joesoef R, Marchbanks PA, et al Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503-9
13. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005;106:573-80
14. Hemsell DL, Little BB, Faro S, et al. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin Infect Dis 1994;19:720-7
15. Martens MG, Gordon S, Yarborough DR, Faro S, Binder D, Berkeley A. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. Southern Med J 1993;86:604-10
16. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis 1993;168:969-78
17. Ross JDC, Cronje HS, Paszkowski T, et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect [sti.bmjjournals.com/cgi/rapidpdf/sti.005.019109v2] 2006
18. Heystek MJ, Tellarini M, Schmitz H, Krasemann C. Efficacy and safety of moxifloxacin vs ciprofloxacin plus doxycycline plus metronidazole for the treatment of uncomplicated pelvic inflammatory disease. Presented at the 21st International Congress of Chemotherapy, Birmingham, UK, 1999. J Antimicrob Chemother 1999 1999;44(Suppl. A):Abstract P-466
19. Wendel Jr GD, Cox SM, Bawdon RE, Theriot SK, Heard MC, Nobles BJ. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. Am J Obstet Gynecol 1991;164 (5 Part 2):1390-6
20. Witte EH, Peters AA, Smit IB, et al. A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease. Eur J Obstet, Gynecol Reprod Biol 1993;50:153-8
21. Heinonen PK, Teisala K, Miettinen A, Aine R, Punnonen R, Gronroos P. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Scand J Infect Dis - Suppl 1989;60:66-73
22. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 2003;188:141-8
23. Isaacson DM, Fernadez JA, Frosco M, et al. Levofloxacin: a review of its antibacterial activity. Recent Res Dev Antimicrob Agents Chemother 1996;1:391-439